Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis

Articles: Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection (N Engl J Med 2015;373:2599-2607) Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection (N Engl J Med 2015;373:2608-2617)

Bibliographic Details
Main Author: Ki Tae Yoon
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2016-10-01
Series:The Korean Journal of Gastroenterology
Online Access:http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.68.4.229
id doaj-adf7df24dd7b4f1cbde7ff1940c1b776
record_format Article
spelling doaj-adf7df24dd7b4f1cbde7ff1940c1b7762020-11-25T02:45:47ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922016-10-0168422923210.4166/kjg.2016.68.4.229kjg.2016.68.4.229Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver CirrhosisKi Tae Yoon0Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, KoreaArticles: Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection (N Engl J Med 2015;373:2599-2607) Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection (N Engl J Med 2015;373:2608-2617)http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.68.4.229
collection DOAJ
language English
format Article
sources DOAJ
author Ki Tae Yoon
spellingShingle Ki Tae Yoon
Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
The Korean Journal of Gastroenterology
author_facet Ki Tae Yoon
author_sort Ki Tae Yoon
title Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
title_short Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
title_full Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
title_fullStr Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
title_full_unstemmed Direct Acting Antivirals Which Is Effective in Pan-genotypic Chronic Hepatitis C Patients with or without Liver Cirrhosis
title_sort direct acting antivirals which is effective in pan-genotypic chronic hepatitis c patients with or without liver cirrhosis
publisher Jin Publishing & Printing Co.
series The Korean Journal of Gastroenterology
issn 1598-9992
publishDate 2016-10-01
description Articles: Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection (N Engl J Med 2015;373:2599-2607) Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection (N Engl J Med 2015;373:2608-2617)
url http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.68.4.229
work_keys_str_mv AT kitaeyoon directactingantiviralswhichiseffectiveinpangenotypicchronichepatitiscpatientswithorwithoutlivercirrhosis
_version_ 1724760131739058176